"10.1371_journal.pone.0065858","plos one","2013-06-06T00:00:00Z","Jordi Alonso; Gemma Vilagut; Núria D Adroher; Somnath Chatterji; Yanling He; Laura Helena Andrade; Evelyn Bromet; Ronny Bruffaerts; John Fayyad; Silvia Florescu; Giovanni de Girolamo; Oye Gureje; Josep Maria Haro; Hristo Hinkov; Chiyi Hu; Noboru Iwata; Sing Lee; Daphna Levinson; Jean Pierre Lépine; Herbert Matschinger; Maria Elena Medina-Mora; Siobhan O'Neill; J Hormel; Jose A Posada-Villa; Nezar Ismet Taib; Miguel Xavier; Ronald C Kessler","IMIM-Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain; Pompeu Fabra University, Barcelona, Spain; CIBER en Epidemiología y Salud Pública, Barcelona, Spain; World Health Organization, Geneva, Switzerland; Shangai Mental Health Center, Shangai, People's Republic of China; Institute of Psychiatry University of São Paulo Medical School, São Paulo, Brazil; State University of New York at Stony Brook, Stony Brook, New York, United States of America; Universitair Psychiatrisch Centrum - Katholieke Universiteit Leuven, Leuven, Belgium; Institute for Development Research, Advocacy, and Applied Care, Beirut, Lebanon; St. George Hospital University Medical Center, Beirut, Lebanon; National School of Public Health Management and Professional Development, Bucharest, Romania; IRCCS Centro S. Giovanni di Dio Fatebenefratelli, Brescia, Italy; University College Hospital, Ibadan, Nigeria; Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain; CIBERSAM, Sant Boi de Llobregat, Barcelona, Spain; National Center for Public Health Protection, Sofia, Bulgaria; Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, People's Republic of China; Hiroshima International University, Higashi-Hiroshima, Japan; The Chinese University of Hong Kong, Shatin, HKSAR; Ministry of Health, Jerusalem, Israel; Hôpital Saint-Louis Lariboisière Fernand Widal, Paris, France; Universität Leipzig, Leipzig, Germany; Instituto Nacional de Psiquiatria Ramon de la Fuente, Mexico City, Mexico; University of Ulster, Londonderry, United Kingdom; University Medical Center Groningen, Groningen, The Netherlands; Pontificia Universidad Javeriana, Bogota D.C., Colombia; Mental Health Center-Duhok, Kurdistan Region, Iraq; Universidade Nova de Lisboa, Lisbon, Portugal; Harvard Medical School, Boston, Massachusetts, United States of America","Conceived and designed the experiments: JA SC RCK. Analyzed the data: JA GV ND SC EB RB JH RCK. Acquisition of data: JA GV YH LHA EB RB JF SF GG OG JMH HH CH NI SL DL JPL HM MEM SO JH JAP NI MX RCK. Drafting the article: JA GV ND SC YH LHA EB RB JF SF GG OG JMH HH CH NI SL DL JPL HM MEM SO JH JAP NI MX RCK. Final approval: JA GV ND SC YH LHA EB RB JF SF GG OG JMH HH CH NI SL DL JPL HM MEM SO JH JAP NI MX RCK.","Dr. Kessler has been a consultant for AstraZeneca, Analysis Group, Bristol-Myers Squibb, Cerner-Galt Associates, Eli Lilly & Company, GlaxoSmithKline Inc., HealthCore Inc., Health Dialog, Hoffman-LaRoche, Inc., Integrated Benefits Institute, John Snow Inc., Kaiser Permanente, Matria Inc., Mensante, Merck & Co, Inc., Ortho-McNeil Janssen Scientific Affairs, Pfizer Inc., Primary Care Network, Research Triangle Institute, Sanofi-Aventis Groupe, Shire US Inc., SRA International, Inc., Takeda Global Research & Development, Transcept Pharmaceuticals Inc., and Wyeth-Ayerst. Dr. Kessler has served on advisory boards for Appliance Computing II, Eli Lilly & Company, Mindsite, Ortho-McNeil Janssen Scientific Affairs, Johnson & Johnson, Plus One Health Management and Wyeth-Ayerst. Dr. Kessler has had research support for his epidemiological studies from Analysis Group Inc., Bristol-Myers Squibb, Eli Lilly & Company, EPI-Q, GlaxoSmithKline, Johnson & Johnson Pharmaceuticals, Ortho-McNeil Janssen Scientific Affairs., Pfizer Inc., Sanofi-Aventis Groupe, Shire US, Inc., and Walgreens Co. Dr. Kessler owns 25% share in DataStat, Inc. This study was partly funded by Eli Lilly and Company, Ortho-McNeil Pharmaceutical, Inc., GlaxoSmithKline, and Bristol-Myers Squibb. The ESEMeD project is partly funded by an unrestricted educational grant from GlaxoSmithKline. The Lebanese National Mental Health Survey is partly supported by unrestricted grants from Janssen Cilag, Eli Lilly, GlaxoSmithKline, Astra Zeneca, Hikma Pharm and Novartis. The Romania WMH study projects “Policies in Mental Health Area” and “National Study regarding Mental Health and Services Use with technical support of SC. Cheyenne Services SRL. Statistics Netherlands and were partly funded by supplemental support of Eli Lilly Romania SRL. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","06","Jordi Alonso","JA",27,TRUE,3,NA,8,NA,TRUE,TRUE,FALSE,0,NA,FALSE
